Mysimba Price
The price of Mysimba is determined by the pharmacist.
Who is Mysimba suitable for?
Mysimba is prescribed to adult patients with an initial BMI (Body Mass Index) of:
≥ 30 BMI (obesity), or
≥ 27 BMI to < 30 BMI (overweight) who have at least one weight-related comorbidity, such as diabetes, high blood pressure, high cholesterol, osteoarthritis, or sleep apnea.
Treatment with Mysimba should be discontinued if at least 5% of the initial body weight has not been lost after 16 weeks of using the daily dose of 3.0 mg.
Mysimba Prescription
Mysimba is only available with a doctor's prescription if the client meets the indications described above.
The substances contained in Mysimba
The active substances in this medicine are 8 mg naltrexone and 90 mg bupropion. Other substances in this medicine are: microcrystalline cellulose, hydroxypropyl cellulose, anhydrous lactose, lactose monohydrate, cysteine hydrochloride, crospovidone type A, magnesium stearate, hypromellose, disodium edetate, colloidal silicon dioxide, and indigo carmine aluminum lake.
Mysimba Reimbursement by Health Insurer
The medication Mysimba can be reimbursed from the basic package for the treatment of a small group of people with overweight. Reimbursement only applies to people with a Body Mass Index (BMI) of 30 or higher, or 27 or higher with a weight-related condition, who have already participated in a combined lifestyle intervention (GLI) for at least 1 year and have not achieved sufficient weight loss through it.